retatrutide diabetes trial Results: 28.3% Weight Loss Data Phase-3-Retatrutide-trial-sees-participants-achieve-up-to-30-weight-loss

Comprehending the dynamics behind how Glp 1 Agonist work provides clarity regarding their important role not only with respect to diabetes care, but also concerning obesity therapy

Purpose: item } Purpose: item } Purpose: item }

Furuhashi Y et al

PMID: 33755728

doi: 10.3389/fonc.2026.1748136 Received 18 November 2025 Revised 23 March 2026 Accepted 24 March 2026 Published 30 April 2026 Volume 16 - 2026 Edited by Pierfranco Conte, University of Padua, Italy Reviewed by Valeria Conti, University of Salerno, Italy T Mohan Viswanathan, Karpagam Academy of Higher Education, India Updates Copyright 2026 Talath, El-Tanani, Wali, Rabbani, Bhongande, Ibraheem, Avagimyan, Hoffmann, Ilias, Ispas, Viviana, Paczkowska and Rizzo

[1] [2] Dietary modifications form the cornerstone of symptom management: Eat smaller, more frequent meals rather than large portions Avoid high-fat, greasy, or heavily spiced foods that may exacerbate nausea Stay well-hydrated, particularly if experiencing diarrhoea Increase dietary fibre gradually if constipated, alongside adequate fluid intake Limit carbonated beverages and foods that cause bloating Eat slowly and chew food thoroughly to aid digestion For nausea management , patients often find relief by: Avoiding strong food odours during meal preparation Consuming bland, easily digestible foods such as toast, rice, or bananas Using ginger-based products (ginger tea or biscuits), which some patients find helpful Ensuring adequate rest and avoiding lying down immediately after eating Constipation can be addressed through: Increasing water intake to at least 68 glasses daily Regular physical activity, which stimulates bowel motility Gradually increasing dietary fibre from fruits, vegetables, and whole grains Considering over-the-counter laxatives after consulting your pharmacist or GP If side effects are severe or significantly impact quality of life, discuss with your prescriber whether dose adjustment or temporary treatment interruption might be appropriate